tiprankstipranks
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market
ADCT
ADC Therapeutics
RESEARCH TOOLSreports
Want to see ADCT full AI Analyst Report?

ADC Therapeutics (ADCT) Income Statement

415 Followers

ADC Therapeutics Income Statement

Last quarter (Q4 2025), ADC Therapeutics's total revenue was $23.06M, an increase of 36.36% from the same quarter last year. In Q4, ADC Therapeutics's net income was $-6.41M. See ADC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 81.36M$ 70.84M$ 69.56M$ 209.91M$ 33.92M
Gross Profit
$ 73.68M$ 64.89M$ 67.03M$ 206.61M$ 32.52M
Operating Expenses
$ 182.06M$ 195.54M$ 233.01M$ 329.95M$ 294.24M
Depreciation and Amortization
$ 1.88M$ 3.28M$ 3.27M$ 2.39M$ 2.63M
EBITDA
$ -106.50M$ -102.65M$ -145.83M$ -107.70M$ -230.53M
Operating Income
$ -108.38M$ -130.65M$ -165.99M$ -123.34M$ -261.72M
Other Income/Expenses
$ -34.40M$ -27.03M$ -34.96M$ -33.56M$ 10.21M
Pretax Income
$ -142.78M$ -157.68M$ -200.95M$ -156.90M$ -251.50M
Net Income
$ -142.62M$ -157.85M$ -240.05M$ -157.13M$ -230.03M
Per Share Metrics
Basic EPS
$ -1.12$ -1.62$ -2.94$ -1.99$ -3.00
Diluted EPS
$ -1.12$ -1.62$ -2.94$ -1.99$ -3.00
Weighted Average Shares Outstanding
 127.07M 97.16M 81.71M 78.15M 76.75M
Weighted Average Shares Outstanding (Diluted)
 127.07M 97.16M 81.71M 78.15M 76.75M
Currency in USD

ADC Therapeutics Earnings and Revenue History